Last 7 days
-2.7%
Last 30 days
-8.4%
Last 90 days
-15.1%
Trailing 12 Months
-27.9%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
WMT | 374.9B | 600.1B | -4.30% | -2.71% | 41.59 | 0.62 | 4.92% | 10.07% |
COST | 216.1B | 234.4B | -4.11% | -9.98% | 35.72 | 0.92 | 13.76% | 13.92% |
SYY | 37.8B | 73.6B | -4.15% | -1.87% | 26.63 | 0.51 | 21.14% | 80.80% |
KR | 33.7B | 146.5B | 8.20% | -12.77% | 14.27 | 0.23 | 8.04% | 132.09% |
WBA | 28.9B | 132.2B | -8.42% | -27.88% | -9.73 | 0.22 | -2.07% | -146.10% |
BJ | 10.2B | 18.7B | 1.09% | 19.41% | 20.77 | 0.54 | 15.30% | 18.31% |
MID-CAP | ||||||||
USFD | 7.8B | 34.1B | -3.51% | 0.68% | 29.36 | 0.23 | 15.50% | 61.59% |
CASY | 7.8B | 15.2B | -6.90% | 12.62% | 17.23 | 0.51 | 28.24% | 39.99% |
SFM | 3.5B | 6.4B | 1.67% | 6.45% | 13.39 | 0.55 | 4.99% | 6.97% |
GO | 2.6B | 3.6B | -8.20% | -8.94% | 40.69 | 0.74 | 16.19% | 4.40% |
WMK | 2.2B | 4.7B | -3.05% | 10.53% | 17.82 | 0.48 | 11.16% | 15.02% |
SMALL-CAP | ||||||||
ANDE | 1.3B | 17.3B | 3.29% | -6.09% | 10.24 | 0.08 | 37.37% | 26.06% |
CHEF | 1.2B | 2.6B | -15.59% | 11.83% | 44.52 | 0.47 | 49.70% | 663.68% |
RAD | 159.4M | 24.1B | -31.83% | -70.43% | -0.18 | 0.01 | -1.46% | -434.62% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -0.4% | 132,184 | 132,703 | 134,516 | 135,949 | 134,972 |
Gross Profit | -2.2% | 27,643 | 28,264 | 29,357 | 29,938 | 29,011 |
S&GA Expenses | 24.8% | 34,062 | 27,295 | 26,625 | 25,722 | 25,186 |
EBITDA | -142.2% | -2,691 | 6,375 | 7,729 | 8,954 | - |
EBITDA Margin | -142.4% | -0.02* | 0.05* | 0.06* | 0.07* | - |
Earnings Before Taxes | -228.0% | -5,099 | 3,985 | 5,650 | 6,417 | 6,416 |
EBT Margin | -228.5% | -0.04* | 0.03* | 0.04* | 0.05* | - |
Interest Expenses | 5.8% | 423 | 400 | 382 | 819 | 856 |
Net Income | -168.3% | -2,964 | 4,337 | 5,379 | 6,287 | 6,430 |
Net Income Margin | -168.6% | -0.02* | 0.03* | 0.04* | 0.05* | - |
Free Cahsflow | -35.2% | 1,403 | 2,165 | 3,439 | 3,626 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 3.1% | 92,875 | 90,124 | 92,759 | 92,683 | 96,507 |
Current Assets | 15.5% | 19,523 | 16,902 | 18,872 | 16,824 | 20,314 |
Cash Equivalents | 73.0% | 2,349 | 1,358 | 2,285 | 1,887 | 4,268 |
Inventory | 11.6% | 9,322 | 8,353 | 8,520 | 8,947 | 9,475 |
Goodwill | 1.4% | 22,582 | 22,280 | 21,901 | 21,958 | 8,166 |
Liabilities | 14.1% | 68,137 | 59,717 | 61,602 | 61,004 | 63,141 |
Current Liabilities | 24.1% | 28,036 | 22,583 | 24,067 | 22,699 | 24,447 |
. Short Term Borrowings | 271.9% | 3,938 | 1,059 | 2,787 | 2,105 | 2,647 |
LT Debt, Non Current | -26.6% | 7,789 | 10,615 | 10,670 | 11,203 | 11,199 |
Shareholder's Equity | -18.6% | 20,576 | 25,275 | 26,253 | 30,867 | 30,579 |
Retained Earnings | -10.9% | 33,664 | 37,801 | 38,632 | 38,757 | 38,286 |
Additional Paid-In Capital | -4.3% | 10,477 | 10,950 | 11,029 | 10,973 | 10,966 |
Accumulated Depreciation | -3.7% | 13,000 | 13,500 | 13,300 | - | - |
Shares Outstanding | 0.0% | 864 | 864 | - | - | - |
Minority Interest | -2.1% | 4,006 | 4,091 | 4,316 | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -15.5% | 3,293 | 3,899 | 5,058 | 5,183 | 5,459 |
Share Based Compensation | 47.8% | 578 | 391 | 301 | 255 | 154 |
Cashflow From Investing | 358.6% | 2,752 | -1,064 | 4,151 | 3,247 | 2,373 |
Cashflow From Financing | -298.6% | -5,975 | -1,499 | -6,427 | -7,620 | -4,807 |
Dividend Payments | 0.1% | 1,661 | 1,659 | 1,656 | 1,642 | 1,625 |
Buy Backs | -2.1% | 183 | 187 | 187 | 187 | 154 |
82.7%
47.3%
21.5%
Y-axis is the maximum loss one would have experienced if Walgreens Boots Alliance was unfortunately bought at previous high price.
0.1%
-9.3%
-10.0%
-6.5%
FIve years rolling returns for Walgreens Boots Alliance.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -9.22 | 188,402 | 2,548,400 | 0.07% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -20.01 | -3,369,670 | 66,373,300 | 0.07% |
2023-03-08 | SHEETS SMITH WEALTH MANAGEMENT | new | - | 4,341,980 | 4,341,980 | 0.68% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 20.68 | 1,369,000 | 4,508,000 | 0.02% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | reduced | -4.68 | 49,694 | 418,694 | 0.03% |
2023-03-03 | TIAA, FSB | added | 37.7 | 619,453 | 1,590,450 | 0.01% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 857,300 | 857,300 | 0.01% |
2023-03-01 | Regal Investment Advisors LLC | added | 64.00 | 212,193 | 436,193 | 0.04% |
2023-03-01 | Lakewood Asset Management LLC | new | - | 36,000 | 36,000 | 0.03% |
2023-02-28 | Voya Investment Management LLC | reduced | -3.58 | 2,416,690 | 18,828,700 | 0.03% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 7.13% | 61,519,967 | SC 13G/A | |
Feb 07, 2023 | state street corp | 6.68% | 57,573,619 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.0% | 60,606,871 | SC 13G/A | |
Feb 14, 2022 | state street corp | 5.45% | 47,095,044 | SC 13G/A | |
Feb 07, 2022 | blackrock inc. | 6.4% | 55,032,519 | SC 13G/A | |
Feb 11, 2021 | state street corp | 5.43% | 46,922,371 | SC 13G | |
Feb 10, 2021 | vanguard group inc | 6.72% | 58,059,957 | SC 13G/A | |
Feb 01, 2021 | blackrock inc. | 5.8% | 49,962,675 | SC 13G/A | |
Jul 27, 2020 | alliance sante participations s.a. | 16.7% | 144,788,821 | SC 13D/A | |
Feb 14, 2020 | state street corp | 5.26% | 46,702,228 | SC 13G |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 46.11 38.01% | 54.62 63.48% | 68.26 104.31% | 97.80 192.73% | 139.48 317.48% |
Current Inflation | 43.06 28.88% | 50.40 50.85% | 61.92 85.33% | 86.76 159.68% | 121.57 263.87% |
Very High Inflation | 39.24 17.45% | 45.22 35.35% | 54.31 62.56% | 73.87 121.10% | 101.03 202.39% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | SC 13D/A | 13D - Major Acquisition | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 07, 2023 | SC 13G/A | Major Ownership Report | |
Jan 31, 2023 | 8-K | Current Report | |
Jan 31, 2023 | SC 13G/A | Major Ownership Report | |
Jan 30, 2023 | 4 | Insider Trading | |
Jan 30, 2023 | 4 | Insider Trading | |
Jan 30, 2023 | 4 | Insider Trading | |
Jan 05, 2023 | 10-Q | Quarterly Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2022-11-18 | Ban Kevin M. | sold | -414,108 | 40.193 | -10,303 | evp, chief medical officer |
2022-11-18 | Ban Kevin M. | acquired | 350,714 | 34.04 | 10,303 | evp, chief medical officer |
2022-11-17 | SCHLICHTING NANCY M | sold | -660,928 | 39.887 | -16,570 | - |
2022-11-01 | SHULMAN STEVEN J | acquired | - | - | 4,136 | - |
2022-11-01 | BREWER ROSALIND G | sold (taxes) | -338,161 | 36.26 | -9,326 | ceo |
2022-11-01 | Kehoe James | acquired | - | - | 60,818 | evp and global cfo |
2022-11-01 | Kehoe James | sold (taxes) | -423,444 | 36.26 | -11,678 | evp and global cfo |
2022-11-01 | Gray Danielle | sold (taxes) | -44,563 | 36.26 | -1,229 | evp and global clo |
2022-11-01 | SCHLICHTING NANCY M | acquired | - | - | 5,515 | - |
2022-11-01 | Mahajan Manmohan | sold (taxes) | -29,551 | 36.26 | -815 | svp, global controller and cao |
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
---|---|---|
Nov. 30, 2022 | Nov. 30, 2021 | |
Income Statement [Abstract] | ||
Sales | $ 33,382 | $ 33,901 |
Cost of sales | 26,429 | 26,326 |
Gross profit | 6,953 | 7,574 |
Selling, general and administrative expenses | 13,158 | 6,391 |
Equity earnings in AmerisourceBergen | 53 | 100 |
Operating (loss) income | (6,151) | 1,283 |
Other income, net | 992 | 2,617 |
(Loss) earnings before interest and income tax (benefit) provision | (5,159) | 3,900 |
Interest expense, net | 110 | 86 |
(Loss) earnings before income tax (benefit) provision | (5,270) | 3,814 |
Income tax (benefit) provision | (1,447) | 275 |
Post-tax earnings (loss) from other equity method investments | 7 | (7) |
Net (loss) earnings | (3,816) | 3,531 |
Net loss attributable to non-controlling interests | (94) | (48) |
Net (loss) earnings attributable to Walgreens Boots Alliance, Inc. | (3,721) | 3,580 |
Net (loss) earnings per common share: | ||
Net Income (Loss) Attributable to Parent, Total | $ (3,721) | $ 3,580 |
Earnings Per Share, Basic [Abstract] | ||
Total (in dollars per share) | $ (4.31) | $ 4.13 |
Earnings Per Share, Diluted [Abstract] | ||
Total (in dollars per share) | $ (4.31) | $ 4.13 |
Weighted average common shares outstanding: | ||
Basic (in shares) | 863.6 | 865.8 |
Diluted (in shares) | 863.6 | 867.6 |
CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($) $ in Millions | Nov. 30, 2022 | Aug. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 2,349 | $ 1,358 |
Marketable securities | 1,883 | 1,114 |
Accounts receivable, net | 4,853 | 5,017 |
Inventories | 9,322 | 8,353 |
Other current assets | 1,115 | 1,059 |
Total current assets | 19,523 | 16,902 |
Non-current assets: | ||
Property, plant and equipment, net | 11,450 | 11,729 |
Operating lease right-of-use assets | 21,240 | 21,259 |
Goodwill | 22,582 | 22,280 |
Intangible assets, net | 10,612 | 10,730 |
Equity method investments (see Note 5) | 4,426 | 5,495 |
Other non-current assets | 3,042 | 1,730 |
Total non-current assets | 73,352 | 73,222 |
Total assets | 92,875 | 90,124 |
Current liabilities: | ||
Short-term debt | 3,938 | 1,059 |
Trade accounts payable (see Note 16) | 12,184 | 11,255 |
Operating lease obligations | 2,271 | 2,286 |
Accrued expenses and other liabilities | 9,534 | 7,899 |
Income taxes | 109 | 84 |
Total current liabilities | 28,036 | 22,583 |
Non-current liabilities: | ||
Long-term debt | 7,789 | 10,615 |
Operating lease obligations | 21,514 | 21,517 |
Deferred income taxes | 1,319 | 1,442 |
Accrued litigation obligations | 6,427 | 551 |
Other non-current liabilities | 3,052 | 3,009 |
Total non-current liabilities | 40,101 | 37,134 |
Commitments and contingencies (see Note 10) | ||
Total liabilities | 68,137 | 59,717 |
Redeemable non-controlling interests | 157 | 1,042 |
Equity: | ||
Preferred stock $.01 par value; authorized 32 million shares, none issued | 0 | 0 |
Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at November 30, 2022 and August 31, 2022 | 12 | 12 |
Paid-in capital | 10,477 | 10,950 |
Retained earnings | 33,664 | 37,801 |
Accumulated other comprehensive loss | (2,815) | (2,805) |
Treasury stock, at cost; 310,171,383 shares at November 30, 2022 and 307,874,161 shares at August 31, 2022 | (20,762) | (20,683) |
Total Walgreens Boots Alliance, Inc. shareholders’ equity | 20,576 | 25,275 |
Non-controlling interests | 4,006 | 4,091 |
Total equity | 24,582 | 29,366 |
Total liabilities, redeemable non-controlling interests and equity | $ 92,875 | $ 90,124 |